marketcaparena
Search

    CVS

    CVS HEALTH Corp

    Company overview

    Market capitalization
    $112.36B
    Employees
    219,000
    Latest publication
    2026-09-29
    About CVS HEALTH Corp

    CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

    Company website

    Financial statements

    Income YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Total Revenue206,522,000,000USD
    Cost Of Revenue114,306,000,000USD
    Other Operating Expenses21,990,000,000USD
    Total Operating Expenses82,833,000,000USD
    Operating Income9,383,000,000USD
    Total Other Income Expense Net-1,468,000,000USD
    Interest Expense1,531,000,000USD
    Income Before Tax7,915,000,000USD
    Income Tax Expense1,963,000,000USD
    Net Income5,952,000,000USD
    Minority Interest30,000,000USD
    Net Income Applicable To Common Shares5,922,000,000USD
    SourceDisclosureDeterministicFinal

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USDQ4 20232023-12-31 · USD
    Total Revenue106,096,000,000USD100,426,000,000USD105,693,000,000USD98,915,000,000USD94,588,000,000USD91,234,000,000USD88,437,000,000USD93,813,000,000USD
    Cost Of Revenue58,862,000,000USD55,444,000,000USD92,126,000,000USD85,322,000,000USD80,192,000,000USD77,851,000,000USD75,876,000,000USD79,937,000,000USD
    Other Operating Expenses11,046,000,000USD10,944,000,000USD——————
    Total Operating Expenses42,531,000,000USD40,302,000,000USD11,455,000,000USD11,212,000,000USD11,022,000,000USD10,338,000,000USD10,290,000,000USD10,503,000,000USD
    Operating Income4,703,000,000USD4,680,000,000USD2,112,000,000USD2,381,000,000USD3,374,000,000USD3,045,000,000USD2,271,000,000USD3,373,000,000USD
    Total Other Income Expense Net-726,000,000USD-742,000,000USD-758,000,000USD-734,000,000USD-757,000,000USD-708,000,000USD-691,000,000USD-668,000,000USD
    Interest Expense757,000,000USD774,000,000USD787,000,000USD763,000,000USD785,000,000USD732,000,000USD716,000,000USD690,000,000USD
    Income Before Tax3,977,000,000USD3,938,000,000USD1,354,000,000USD1,647,000,000USD2,617,000,000USD2,337,000,000USD1,580,000,000USD2,705,000,000USD
    Income Tax Expense982,000,000USD981,000,000USD-1,569,000,000USD634,000,000USD835,000,000USD569,000,000USD456,000,000USD658,000,000USD
    Net Income2,995,000,000USD2,957,000,000USD2,943,000,000USD1,021,000,000USD1,779,000,000USD1,770,000,000USD1,113,000,000USD2,046,000,000USD
    Minority Interest16,000,000USD14,000,000USD20,000,000USD8,000,000USD-3,000,000USD2,000,000USD-11,000,000USD-1,000,000USD
    Net Income Applicable To Common Shares2,979,000,000USD2,943,000,000USD2,943,000,000USD1,021,000,000USD1,779,000,000USD———
    Gross Profit—44,982,000,000USD13,567,000,000USD13,593,000,000USD14,396,000,000USD13,383,000,000USD12,561,000,000USD13,876,000,000USD
    Unclassified Operating Expenses——11,455,000,000USD11,212,000,000USD11,022,000,000USD10,338,000,000USD10,290,000,000USD333,000,000USD
    Interest Income——787,000,000USD763,000,000USD785,000,000USD———
    Net Interest Income——-787,000,000USD-763,000,000USD-785,000,000USD-732,000,000USD-716,000,000USD-690,000,000USD
    Tax Provision——-1,569,000,000USD634,000,000USD835,000,000USD569,000,000USD456,000,000USD658,000,000USD
    Net Income From Continuing Ops——2,923,000,000USD1,013,000,000USD1,782,000,000USD1,768,000,000USD1,124,000,000USD2,047,000,000USD
    Ebit——2,141,000,000USD2,410,000,000USD3,402,000,000USD3,069,000,000USD2,296,000,000USD3,395,000,000USD
    Ebitda——3,288,000,000USD3,581,000,000USD4,556,000,000USD4,220,000,000USD3,434,000,000USD4,529,000,000USD
    Depreciation And Amortization——1,147,000,000USD1,171,000,000USD1,154,000,000USD1,151,000,000USD1,138,000,000USD1,134,000,000USD
    Reconciled Depreciation——1,147,000,000USD1,171,000,000USD1,154,000,000USD1,151,000,000USD1,138,000,000USD1,134,000,000USD
    Selling General Administrative———————9,185,000,000USD
    Selling And Marketing Expenses———————985,000,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20242024-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USD
    Total Revenue372,809,000,000USD322,467,000,000USD292,111,000,000USD268,706,000,000USD256,776,000,000USD184,786,000,000USD177,546,000,000USD153,290,000,000USD
    Cost Of Revenue321,408,000,000USD267,965,000,000USD239,991,000,000USD219,660,000,000USD211,248,000,000USD156,258,000,000USD148,712,000,000USD126,762,000,000USD
    Gross Profit51,401,000,000USD54,502,000,000USD52,120,000,000USD49,046,000,000USD45,528,000,000USD28,528,000,000USD28,834,000,000USD26,528,000,000USD
    Selling General Administrative40,240,000,000USD37,177,000,000USD36,227,000,000USD34,459,000,000USD32,229,000,000USD18,290,000,000USD18,056,000,000USD16,633,000,000USD
    Selling And Marketing Expenses989,000,000USD745,000,000USD707,000,000USD613,000,000USD396,000,000USD230,000,000USD216,000,000USD221,000,000USD
    Unclassified Operating Expenses1,656,000,000USD8,626,000,000USD1,876,000,000USD—916,000,000USD470,000,000USD—199,000,000USD
    Total Operating Expenses42,885,000,000USD46,548,000,000USD38,810,000,000USD35,135,000,000USD33,541,000,000USD18,990,000,000USD18,448,000,000USD17,053,000,000USD
    Operating Income8,516,000,000USD7,954,000,000USD13,310,000,000USD13,911,000,000USD11,987,000,000USD9,538,000,000USD10,386,000,000USD9,475,000,000USD
    Interest Income2,958,000,000USD2,287,000,000USD2,503,000,000USD2,907,000,000USD3,035,000,000USD21,000,000USD20,000,000USD838,000,000USD
    Interest Expense2,958,000,000USD2,287,000,000USD2,503,000,000USD2,907,000,000USD3,035,000,000USD1,062,000,000USD1,080,000,000USD859,000,000USD
    Net Interest Income-2,958,000,000USD-2,287,000,000USD-2,503,000,000USD-2,907,000,000USD-3,035,000,000USD-1,041,000,000USD-1,058,000,000USD—
    Income Before Tax6,148,000,000USD5,836,000,000USD10,537,000,000USD9,770,000,000USD8,997,000,000USD8,268,000,000USD8,637,000,000USD8,616,000,000USD
    Income Tax Expense1,562,000,000USD1,509,000,000USD2,548,000,000USD2,569,000,000USD2,366,000,000USD1,637,000,000USD3,317,000,000USD3,386,000,000USD
    Tax Provision1,562,000,000USD1,463,000,000USD2,522,000,000USD2,569,000,000USD2,366,000,000USD1,637,000,000USD3,317,000,000USD3,386,000,000USD
    Net Income4,614,000,000USD4,311,000,000USD8,001,000,000USD7,179,000,000USD6,634,000,000USD6,622,000,000USD5,317,000,000USD5,237,000,000USD
    Net Income From Continuing Ops4,586,000,000USD4,165,000,000USD7,898,000,000USD7,201,000,000USD6,631,000,000USD6,631,000,000USD5,320,000,000USD5,230,000,000USD
    Ebit9,086,000,000USD8,123,000,000USD13,040,000,000USD12,677,000,000USD12,032,000,000USD9,330,000,000USD9,715,000,000USD9,475,000,000USD
    Ebitda13,683,000,000USD12,347,000,000USD17,526,000,000USD17,118,000,000USD16,403,000,000USD11,809,000,000USD12,190,000,000USD11,567,000,000USD
    Depreciation And Amortization4,597,000,000USD4,224,000,000USD4,486,000,000USD4,441,000,000USD4,371,000,000USD2,479,000,000USD2,475,000,000USD2,092,000,000USD
    Reconciled Depreciation4,597,000,000USD4,247,000,000USD4,512,000,000USD4,441,000,000USD4,371,000,000USD2,479,000,000USD——
    Total Other Income Expense Net-2,368,000,000USD-2,118,000,000USD-2,773,000,000USD-4,141,000,000USD-2,990,000,000USD-1,270,000,000USD-1,749,000,000USD-859,000,000USD
    Minority Interest28,000,000USD16,000,000USD-12,000,000USD13,000,000USD-3,000,000USD1,000,000USD2,000,000USD2,000,000USD
    Net Income Applicable To Common Shares4,614,000,000USD4,149,000,000USD7,910,000,000USD7,179,000,000USD6,634,000,000USD6,622,000,000USD5,317,000,000USD5,237,000,000USD
    Non Operating Income Net Other—169,000,000USD-270,000,000USD-1,234,000,000USD45,000,000USD-208,000,000USD-643,000,000USD—
    Discontinued Operations———-9,000,000USD-9,000,000USD-8,000,000USD-1,000,000USD9,000,000USD
    Research Development—————0USD0USD0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets253,768,000,000USD252,974,000,000USD261,064,000,000USD255,327,000,000USD258,343,000,000USD255,585,000,000USD253,215,000,000USD252,427,000,000USD
    Cash And Equivalents11,329,000,000USD9,542,000,000USD8,453,000,000USD9,098,000,000USD11,787,000,000USD10,076,000,000USD8,586,000,000USD6,875,000,000USD
    Cash And Short Term Investments13,958,000,000USD11,802,000,000USD10,657,000,000USD11,289,000,000USD14,216,000,000USD12,654,000,000USD10,993,000,000USD9,680,000,000USD
    Short Term Investments2,629,000,000USD2,260,000,000USD2,145,000,000USD2,134,000,000USD2,386,000,000USD2,578,000,000USD2,407,000,000USD2,805,000,000USD
    Long Term Investments33,247,000,000USD32,407,000,000USD32,669,000,000USD31,553,000,000USD29,858,000,000USD28,906,000,000USD28,934,000,000USD28,939,000,000USD
    Total Current Assets75,346,000,000USD74,817,000,000USD74,714,000,000USD77,109,000,000USD75,649,000,000USD73,191,000,000USD68,645,000,000USD67,343,000,000USD
    Other Current Assets3,457,000,000USD4,253,000,000USD5,032,000,000USD3,001,000,000USD3,335,000,000USD3,527,000,000USD3,076,000,000USD3,835,000,000USD
    Other Non Current Assets7,434,000,000USD7,424,000,000USD——————
    Total Liabilities173,869,000,000USD175,337,000,000USD——————
    Total Current Liabilities87,041,000,000USD86,406,000,000USD88,692,000,000USD92,695,000,000USD94,162,000,000USD88,961,000,000USD84,609,000,000USD84,627,000,000USD
    Other Current Liabilities22,477,000,000USD22,258,000,000USD——————
    Other Non Current Liabilities6,112,000,000USD6,707,000,000USD——————
    Total Stockholder Equity79,702,000,000USD77,456,000,000USD75,214,000,000USD72,928,000,000USD77,379,000,000USD76,929,000,000USD75,560,000,000USD74,944,000,000USD
    Total Equity Including Noncontrolling Interest79,899,000,000USD77,637,000,000USD——————
    Short Long Term Debt1,958,000,000USD—4,068,000,000USD5,328,000,000USD9,200,000,000USD5,670,000,000USD5,743,000,000USD5,710,000,000USD
    Long Term Debt59,452,000,000USD60,531,000,000USD60,502,000,000USD60,508,000,000USD57,290,000,000USD59,040,000,000USD60,527,000,000USD59,824,000,000USD
    Net Receivables40,309,000,000USD40,992,000,000USD39,779,000,000USD43,857,000,000USD40,651,000,000USD39,625,000,000USD36,469,000,000USD36,179,000,000USD
    Inventory17,622,000,000USD17,770,000,000USD19,246,000,000USD18,962,000,000USD17,447,000,000USD17,385,000,000USD18,107,000,000USD17,649,000,000USD
    Property Plant Equipment Net27,619,000,000USD27,778,000,000USD28,056,000,000USD28,109,000,000USD28,337,000,000USD28,560,000,000USD28,937,000,000USD28,959,000,000USD
    Goodwill85,478,000,000USD85,478,000,000USD——————
    Intangible Assets24,644,000,000USD25,070,000,000USD25,508,000,000USD25,984,000,000USD26,224,000,000USD26,570,000,000USD27,323,000,000USD27,817,000,000USD
    Accounts Payable17,167,000,000USD16,922,000,000USD59,384,000,000USD60,947,000,000USD17,258,000,000USD16,534,000,000USD15,892,000,000USD15,713,000,000USD
    Retained Earnings65,398,000,000USD63,282,000,000USD61,196,000,000USD59,107,000,000USD63,936,000,000USD63,768,000,000USD62,837,000,000USD62,038,000,000USD
    Accumulated Other Comprehensive Income188,000,000USD201,000,000USD406,000,000USD416,000,000USD272,000,000USD59,000,000USD-120,000,000USD209,000,000USD
    Short Term Debt—1,904,000,000USD5,805,000,000USD7,237,000,000USD11,106,000,000USD7,579,000,000USD7,494,000,000USD7,622,000,000USD
    Total Liab——185,682,000,000USD182,217,000,000USD180,792,000,000USD178,475,000,000USD177,485,000,000USD177,321,000,000USD
    Other Current Liab——23,441,000,000USD24,453,000,000USD65,798,000,000USD64,848,000,000USD61,223,000,000USD61,292,000,000USD
    Common Stock——18,000,000USD50,181,000,000USD18,000,000USD49,837,000,000USD49,661,000,000USD49,510,000,000USD
    Capital Stock——50,402,000,000USD50,181,000,000USD50,020,000,000USD49,837,000,000USD49,661,000,000USD49,510,000,000USD
    Good Will——85,478,000,000USD85,478,000,000USD91,203,000,000USD91,203,000,000USD91,272,000,000USD91,272,000,000USD
    Other Assets——7,113,000,000USD7,094,000,000USD7,072,000,000USD7,155,000,000USD8,104,000,000USD8,097,000,000USD
    Cash——8,512,000,000USD9,155,000,000USD11,787,000,000USD10,076,000,000USD8,586,000,000USD6,875,000,000USD
    Current Deferred Revenue——62,000,000USD58,000,000USD———39,154,000,000USD
    Net Debt——85,081,000,000USD72,654,000,000USD70,937,000,000USD71,137,000,000USD74,334,000,000USD75,829,000,000USD
    Short Long Term Debt Total——93,593,000,000USD81,752,000,000USD82,724,000,000USD81,213,000,000USD82,920,000,000USD82,704,000,000USD
    Property Plant Equipment Gross——52,800,000,000USD28,109,000,000USD28,337,000,000USD28,560,000,000USD52,384,000,000USD28,959,000,000USD
    Common Stock Shares Outstanding——1,277,000,000shares1,269,000,000shares1,270,000,000shares1,264,000,000shares1,261,000,000shares1,259,000,000shares
    Non Current Assets Total——186,350,000,000USD178,218,000,000USD182,694,000,000USD182,394,000,000USD184,570,000,000USD185,084,000,000USD
    Non Current Liabilities Total——96,990,000,000USD89,522,000,000USD86,630,000,000USD89,514,000,000USD92,876,000,000USD92,694,000,000USD
    Non Current Liabilities Other——9,493,000,000USD9,526,000,000USD9,551,000,000USD10,292,000,000USD10,333,000,000USD10,646,000,000USD
    Non Currrent Assets Other——6,913,000,000USD6,897,000,000USD6,877,000,000USD7,155,000,000USD8,104,000,000USD8,097,000,000USD
    Net Working Capital——-13,978,000,000USD-15,586,000,000USD-18,513,000,000USD-15,770,000,000USD-15,964,000,000USD-17,284,000,000USD
    Unclassified Current Liabilities——-4,068,000,000USD-5,328,000,000USD-9,200,000,000USD-5,670,000,000USD-5,743,000,000USD-44,864,000,000USD
    Unclassified Non Current Liabilities——26,995,000,000USD19,488,000,000USD19,789,000,000USD20,182,000,000USD22,016,000,000USD22,224,000,000USD
    Unclassified Equity——-36,808,000,000USD-86,957,000,000USD-36,867,000,000USD-86,572,000,000USD-86,479,000,000USD-86,323,000,000USD
    Unclassified Non Current Assets———-6,897,000,000USD-6,877,000,000USD-7,155,000,000USD-8,104,000,000USD-8,097,000,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets261,064,000,000USD253,215,000,000USD249,728,000,000USD228,275,000,000USD232,999,000,000USD230,715,000,000USD222,449,000,000USD196,456,000,000USD
    Intangible Assets25,508,000,000USD27,323,000,000USD29,234,000,000USD24,803,000,000USD29,026,000,000USD31,142,000,000USD33,121,000,000USD36,524,000,000USD
    Other Current Assets5,032,000,000USD3,076,000,000USD3,151,000,000USD3,544,000,000USD5,292,000,000USD5,277,000,000USD5,113,000,000USD4,581,000,000USD
    Total Liab185,682,000,000USD177,485,000,000USD173,092,000,000USD156,506,000,000USD157,618,000,000USD161,014,000,000USD158,279,000,000USD137,913,000,000USD
    Total Stockholder Equity75,214,000,000USD75,560,000,000USD76,461,000,000USD71,469,000,000USD75,075,000,000USD69,389,000,000USD63,864,000,000USD58,225,000,000USD
    Other Current Liab23,441,000,000USD61,223,000,000USD59,579,000,000USD51,127,000,000USD49,412,000,000USD43,801,000,000USD37,434,000,000USD33,099,000,000USD
    Common Stock18,000,000USD18,000,000USD48,992,000,000USD48,193,000,000USD47,377,000,000USD46,513,000,000USD45,972,000,000USD45,440,000,000USD
    Capital Stock50,402,000,000USD49,661,000,000USD48,992,000,000USD48,193,000,000USD47,377,000,000USD46,513,000,000USD45,972,000,000USD45,440,000,000USD
    Retained Earnings61,196,000,000USD62,837,000,000USD61,604,000,000USD56,398,000,000USD54,906,000,000USD49,640,000,000USD45,108,000,000USD40,911,000,000USD
    Good Will85,478,000,000USD91,272,000,000USD91,272,000,000USD78,150,000,000USD79,121,000,000USD79,552,000,000USD79,749,000,000USD78,678,000,000USD
    Other Assets7,113,000,000USD8,104,000,000USD7,910,000,000USD7,604,000,000USD9,801,000,000USD51,046,000,000USD9,059,000,000USD8,930,000,000USD
    Cash8,512,000,000USD8,586,000,000USD8,196,000,000USD12,945,000,000USD9,408,000,000USD7,854,000,000USD5,683,000,000USD4,059,000,000USD
    Cash And Equivalents8,453,000,000USD8,586,000,000USD8,196,000,000USD12,945,000,000USD9,408,000,000USD7,854,000,000USD5,683,000,000USD4,059,000,000USD
    Cash And Short Term Investments10,657,000,000USD10,993,000,000USD11,455,000,000USD15,723,000,000USD12,525,000,000USD10,854,000,000USD8,056,000,000USD6,581,000,000USD
    Total Current Assets74,714,000,000USD68,645,000,000USD67,858,000,000USD65,633,000,000USD60,008,000,000USD56,369,000,000USD50,302,000,000USD45,243,000,000USD
    Total Current Liabilities88,692,000,000USD84,609,000,000USD79,189,000,000USD69,421,000,000USD67,807,000,000USD62,017,000,000USD53,303,000,000USD44,009,000,000USD
    Current Deferred Revenue62,000,000USD—57,112,000,000USD3,880,000,000USD43,808,000,000USD37,974,000,000USD32,613,000,000USD28,223,000,000USD
    Net Debt85,081,000,000USD74,334,000,000USD71,189,000,000USD57,787,000,000USD66,591,000,000USD77,188,000,000USD83,319,000,000USD69,370,000,000USD
    Short Term Debt5,805,000,000USD7,494,000,000USD4,713,000,000USD3,456,000,000USD5,851,000,000USD7,078,000,000USD5,377,000,000USD1,985,000,000USD
    Short Long Term Debt4,068,000,000USD5,743,000,000USD2,972,000,000USD1,778,000,000USD4,205,000,000USD5,440,000,000USD3,781,000,000USD1,985,000,000USD
    Short Long Term Debt Total93,593,000,000USD82,920,000,000USD79,385,000,000USD70,732,000,000USD75,999,000,000USD85,042,000,000USD89,002,000,000USD73,429,000,000USD
    Long Term Debt60,502,000,000USD60,527,000,000USD58,638,000,000USD50,476,000,000USD51,971,000,000USD59,207,000,000USD64,699,000,000USD71,444,000,000USD
    Long Term Investments32,669,000,000USD28,934,000,000USD23,019,000,000USD21,096,000,000USD23,025,000,000USD20,812,000,000USD17,314,000,000USD15,732,000,000USD
    Short Term Investments2,145,000,000USD2,407,000,000USD3,259,000,000USD2,778,000,000USD3,117,000,000USD3,000,000,000USD2,373,000,000USD2,522,000,000USD
    Net Receivables39,779,000,000USD36,469,000,000USD35,227,000,000USD27,276,000,000USD24,431,000,000USD21,742,000,000USD19,617,000,000USD17,631,000,000USD
    Inventory19,246,000,000USD18,107,000,000USD18,025,000,000USD19,090,000,000USD17,760,000,000USD18,496,000,000USD17,516,000,000USD16,450,000,000USD
    Accounts Payable59,384,000,000USD15,892,000,000USD14,897,000,000USD14,838,000,000USD12,544,000,000USD11,138,000,000USD10,492,000,000USD8,925,000,000USD
    Property Plant Equipment Net28,056,000,000USD28,937,000,000USD30,435,000,000USD30,745,000,000USD32,018,000,000USD33,335,000,000USD32,904,000,000USD11,349,000,000USD
    Property Plant Equipment Gross52,800,000,000USD52,384,000,000USD51,134,000,000USD12,873,000,000USD12,896,000,000USD33,335,000,000USD32,904,000,000USD11,349,000,000USD
    Accumulated Other Comprehensive Income406,000,000USD-120,000,000USD-297,000,000USD-1,264,000,000USD965,000,000USD1,414,000,000USD1,019,000,000USD102,000,000USD
    Common Stock Shares Outstanding1,271,000,000shares1,262,000,000shares1,290,000,000shares1,323,000,000shares1,329,000,000shares1,314,000,000shares1,305,000,000shares1,044,000,000shares
    Non Current Assets Total186,350,000,000USD184,570,000,000USD181,870,000,000USD162,642,000,000USD172,991,000,000USD174,346,000,000USD172,147,000,000USD151,213,000,000USD
    Non Current Liabilities Total96,990,000,000USD92,876,000,000USD93,903,000,000USD87,085,000,000USD89,811,000,000USD98,997,000,000USD104,976,000,000USD93,904,000,000USD
    Non Current Liabilities Other9,493,000,000USD10,333,000,000USD11,670,000,000USD32,868,000,000USD31,570,000,000USD32,996,000,000USD32,983,000,000USD14,783,000,000USD
    Non Currrent Assets Other6,913,000,000USD8,104,000,000USD7,910,000,000USD7,848,000,000USD9,801,000,000USD9,505,000,000USD9,059,000,000USD8,930,000,000USD
    Net Working Capital-13,978,000,000USD-15,964,000,000USD-11,331,000,000USD-4,054,000,000USD-7,799,000,000USD-5,648,000,000USD-3,001,000,000USD1,234,000,000USD
    Unclassified Current Liabilities-4,068,000,000USD-5,743,000,000USD-60,084,000,000USD-5,658,000,000USD-48,013,000,000USD-43,414,000,000USD-36,394,000,000USD-30,208,000,000USD
    Unclassified Non Current Liabilities26,995,000,000USD22,016,000,000USD23,595,000,000USD-20,087,000,000USD-19,663,000,000USD-21,033,000,000USD-21,351,000,000USD-22,460,000,000USD
    Unclassified Equity-36,808,000,000USD-36,836,000,000USD-82,830,000,000USD-48,193,000,000USD-47,377,000,000USD-46,513,000,000USD-45,972,000,000USD-45,440,000,000USD
    Unclassified Non Current Assets—-8,104,000,000USD-7,910,000,000USD-7,604,000,000USD-9,801,000,000USD-51,046,000,000USD-9,059,000,000USD-8,930,000,000USD
    Deferred Long Term Liab———3,880,000,000USD6,270,000,000USD6,794,000,000USD7,294,000,000USD7,677,000,000USD
    Other Liab———19,948,000,000USD19,663,000,000USD21,033,000,000USD21,351,000,000USD22,460,000,000USD
    Treasury Stock———-31,858,000,000USD-28,173,000,000USD-28,178,000,000USD-28,235,000,000USD-28,228,000,000USD
    Net Tangible Assets———71,015,000,000USD-33,072,000,000USD-41,305,000,000USD-49,006,000,000USD-56,977,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Net Income5,952,000,000USD
    Depreciation2,241,000,000USD
    Stock Based Compensation442,000,000USD
    Other Non Cash Items-241,000,000USD
    Unclassified Operating Cash Flow0USD
    Change To Account Receivables-533,000,000USD
    Change To Inventory1,624,000,000USD
    Change To Liabilities-246,000,000USD
    Change In Working Capital2,200,000,000USD
    Operating Cash Flow10,594,000,000USD
    Capital Expenditures-1,540,000,000USD
    Net Investments-1,221,000,000USD
    Other Investing Activities3,000,000USD
    Unclassified Investing Cash Flow0USD
    Investing Cash Flow-2,758,000,000USD
    Net Debt Issuance-3,287,000,000USD
    Common Stock Issuance217,000,000USD
    Net Common Stock Issuance-154,000,000USD
    Common Dividends Paid-1,725,000,000USD
    Other Financing Activities-62,000,000USD
    Unclassified Financing Cash Flow0USD
    Financing Cash Flow-5,011,000,000USD
    Effect Of Forex Changes On Cash0USD
    Change In Cash2,825,000,000USD
    End Cash Flow11,537,000,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Depreciation1,115,000,000USD1,147,000,000USD-2,325,000,000USD1,171,000,000USD1,154,000,000USD1,147,000,000USD1,161,000,000USD1,151,000,000USD
    Stock Based Compensation266,000,000USD135,000,000USD-126,000,000USD136,000,000USD126,000,000USD137,000,000USD133,000,000USD133,000,000USD
    Change To Account Receivables-1,205,000,000USD4,039,000,000USD-3,398,000,000USD-1,086,000,000USD-3,053,000,000USD-315,000,000USD-3,784,000,000USD-210,000,000USD
    Change To Inventory1,476,000,000USD-285,000,000USD-1,653,000,000USD-51,000,000USD722,000,000USD-457,000,000USD-1,582,000,000USD277,000,000USD
    Change To Liabilities-758,000,000USD———————
    Change In Working Capital-8,000,000USD-1,021,000,000USD-1,571,000,000USD-309,000,000USD1,427,000,000USD-394,000,000USD-2,379,000,000USD161,000,000USD
    Operating Cash Flow4,249,000,000USD———————
    Capital Expenditures-849,000,000USD-784,000,000USD-698,000,000USD-607,000,000USD-743,000,000USD-768,000,000USD-670,000,000USD-638,000,000USD
    Net Investments2,923,000,000USD———————
    Other Investing Activities-12,000,000USD———————
    Unclassified Investing Cash Flow-2,936,000,000USD—1,141,000,000USD603,000,000USD724,000,000USD742,000,000USD655,000,000USD606,000,000USD
    Investing Cash Flow-874,000,000USD———————
    Net Debt Issuance-1,518,000,000USD———————
    Net Common Stock Issuance-9,000,000USD———————
    Common Dividends Paid-847,000,000USD———————
    Other Financing Activities-47,000,000USD———————
    Unclassified Financing Cash Flow103,000,000USD-308,000,000USD-191,000,000USD-144,000,000USD-144,000,000USD2,662,000,000USD—2,221,000,000USD
    Financing Cash Flow-2,318,000,000USD———————
    Change In Cash1,057,000,000USD-702,000,000USD-2,673,000,000USD1,679,000,000USD1,462,000,000USD1,744,000,000USD-5,680,000,000USD2,713,000,000USD
    End Cash Flow9,769,000,000USD———————
    Net Income—2,943,000,000USD-2,800,000,000USD1,021,000,000USD1,779,000,000USD1,623,000,000USD71,000,000USD1,768,000,000USD
    Other Non Cash Items—-221,000,000USD7,335,000,000USD-8,000,000USD239,000,000USD-993,000,000USD840,000,000USD437,000,000USD
    Total Cash From Operating Activities—3,390,000,000USD796,000,000USD1,897,000,000USD4,556,000,000USD1,860,000,000USD-745,000,000USD3,089,000,000USD
    Free Cash Flow—2,606,000,000USD98,000,000USD1,290,000,000USD3,813,000,000USD1,092,000,000USD-1,415,000,000USD2,451,000,000USD
    Investments—-1,224,000,000USD-2,087,000,000USD-1,024,000,000USD-762,000,000USD-547,000,000USD-3,347,000,000USD-1,625,000,000USD
    Total Cashflows From Investing Activities—-1,998,000,000USD-2,087,000,000USD-1,024,000,000USD-762,000,000USD-547,000,000USD-3,347,000,000USD-1,625,000,000USD
    Net Borrowings—-1,267,000,000USD-671,000,000USD1,761,000,000USD-1,602,000,000USD1,206,000,000USD-869,000,000USD—
    Total Cash From Financing Activities—-2,032,000,000USD-1,382,000,000USD806,000,000USD-2,332,000,000USD431,000,000USD-1,588,000,000USD1,249,000,000USD
    Dividends Paid—-845,000,000USD-846,000,000USD-866,000,000USD-840,000,000USD-838,000,000USD-837,000,000USD-858,000,000USD
    Sale Purchase Of Stock—394,000,000USD308,000,000USD191,000,000USD144,000,000USD-2,662,000,000USD1,000,000USD3,000,000USD
    Begin Period Cash Flow—9,155,000,000USD12,025,000,000USD10,346,000,000USD8,884,000,000USD7,140,000,000USD12,820,000,000USD10,107,000,000USD
    End Period Cash Flow—8,453,000,000USD9,352,000,000USD12,025,000,000USD10,346,000,000USD8,884,000,000USD7,140,000,000USD12,820,000,000USD
    Other Cashflows From Investing Activities—17,000,000USD-443,000,000USD4,000,000USD19,000,000USD26,000,000USD15,000,000USD32,000,000USD
    Other Cashflows From Financing Activities—-6,000,000USD18,000,000USD-136,000,000USD110,000,000USD63,000,000USD117,000,000USD-117,000,000USD
    Unclassified Operating Cash Flow—407,000,000USD283,000,000USD-114,000,000USD-169,000,000USD340,000,000USD-571,000,000USD-561,000,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USD
    Net Income1,728,000,000USD4,586,000,000USD8,368,000,000USD7,192,000,000USD6,631,000,000USD-596,000,000USD6,623,000,000USD5,319,000,000USD
    Depreciation4,606,000,000USD4,597,000,000USD4,366,000,000USD4,441,000,000USD4,371,000,000USD2,718,000,000USD2,479,000,000USD2,475,000,000USD
    Stock Based Compensation535,000,000USD540,000,000USD588,000,000USD400,000,000USD453,000,000USD280,000,000USD234,000,000USD222,000,000USD
    Other Non Cash Items5,142,000,000USD-153,000,000USD765,000,000USD1,243,000,000USD548,000,000USD6,488,000,000USD421,000,000USD778,000,000USD
    Change To Account Receivables-3,498,000,000USD-1,301,000,000USD-6,260,000,000USD-1,510,000,000USD-2,158,000,000USD-1,139,000,000USD-941,000,000USD-243,000,000USD
    Change To Inventory-1,267,000,000USD-102,000,000USD1,233,000,000USD-973,000,000USD-1,075,000,000USD-1,153,000,000USD-514,000,000USD-742,000,000USD
    Change In Working Capital-1,474,000,000USD109,000,000USD15,000,000USD3,159,000,000USD1,499,000,000USD-112,000,000USD-416,000,000USD1,329,000,000USD
    Total Cash From Operating Activities10,639,000,000USD9,107,000,000USD13,426,000,000USD15,865,000,000USD12,848,000,000USD8,865,000,000USD8,007,000,000USD10,141,000,000USD
    Capital Expenditures-2,832,000,000USD-2,781,000,000USD-3,031,000,000USD-2,437,000,000USD-2,457,000,000USD-2,037,000,000USD-1,918,000,000USD-2,224,000,000USD
    Free Cash Flow7,807,000,000USD6,326,000,000USD10,395,000,000USD13,428,000,000USD10,391,000,000USD6,828,000,000USD6,089,000,000USD7,917,000,000USD
    Investments-2,629,000,000USD-7,613,000,000USD-19,766,000,000USD-3,172,000,000USD-485,000,000USD125,000,000USD240,000,000USD256,000,000USD
    Total Cashflows From Investing Activities-5,871,000,000USD-7,613,000,000USD-20,889,000,000USD-5,534,000,000USD-3,339,000,000USD-43,285,000,000USD-2,877,000,000USD-2,470,000,000USD
    Net Borrowings-1,779,000,000USD5,059,000,000USD7,932,000,000USD-5,673,000,000USD-5,320,000,000USD38,265,000,000USD-598,000,000USD-614,000,000USD
    Total Cash From Financing Activities-4,940,000,000USD-1,135,000,000USD2,683,000,000USD-8,155,000,000USD-7,850,000,000USD36,819,000,000USD-6,751,000,000USD-6,761,000,000USD
    Dividends Paid-3,397,000,000USD-3,373,000,000USD-3,132,000,000USD-2,624,000,000USD-2,603,000,000USD-2,038,000,000USD-2,049,000,000USD-1,840,000,000USD
    Sale Purchase Of Stock394,000,000USD-3,023,000,000USD-2,012,000,000USD257,000,000USD185,000,000USD-97,000,000USD-4,361,000,000USD-4,461,000,000USD
    Change In Cash-172,000,000USD359,000,000USD-4,780,000,000USD2,176,000,000USD1,659,000,000USD2,395,000,000USD-1,620,000,000USD912,000,000USD
    Begin Period Cash Flow8,884,000,000USD8,525,000,000USD13,305,000,000USD5,954,000,000USD4,295,000,000USD1,900,000,000USD3,520,000,000USD2,608,000,000USD
    End Period Cash Flow8,712,000,000USD8,884,000,000USD8,525,000,000USD8,130,000,000USD5,954,000,000USD4,295,000,000USD1,900,000,000USD3,520,000,000USD
    Other Cashflows From Investing Activities26,000,000USD101,000,000USD68,000,000USD75,000,000USD-397,000,000USD21,000,000USD298,000,000USD267,000,000USD
    Other Cashflows From Financing Activities1,961,000,000USD202,000,000USD-105,000,000USD10,100,000,000USD3,809,000,000USD592,000,000USD257,000,000USD154,000,000USD
    Unclassified Investing Cash Flow-436,000,000USD2,680,000,000USD1,840,000,000USD——-41,394,000,000USD-1,497,000,000USD-769,000,000USD
    Unclassified Financing Cash Flow-2,119,000,000USD——-10,215,000,000USD-3,921,000,000USD———
    Unclassified Operating Cash Flow—-572,000,000USD-676,000,000USD-570,000,000USD-654,000,000USD—-1,334,000,000USD—
    Change To Liabilities———5,278,000,000USD3,550,000,000USD2,183,000,000USD1,377,000,000USD2,250,000,000USD
    Cash And Cash Equivalents Changes———2,176,000,000USD1,659,000,000USD2,399,000,000USD-1,675,000,000USD912,000,000USD
    Exchange Rate Changes——————1,000,000USD2,000,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    ASC Medical Membership

    Period endPeriodValueUnitSource
    2026-06-30instant16,194,000membersDisclosure

    Commercial Medical Membership

    Period endPeriodValueUnitSource
    2026-06-30instant18,320,000membersDisclosure

    Front-Store Same-Store Sales Growth

    Period endPeriodValueUnitSource
    2026-06-30quarterly1percentDisclosure

    Insured Medical Membership

    Period endPeriodValueUnitSource
    2026-06-30instant9,829,000membersDisclosure

    Medicaid Medical Membership

    Period endPeriodValueUnitSource
    2026-06-30instant2,325,000membersDisclosure

    Medical Benefit Ratio

    Period endPeriodValueUnitSource
    2026-06-30quarterly87.4percentDisclosure

    Medicare Advantage Medical Membership

    Period endPeriodValueUnitSource
    2026-06-30instant4,202,000membersDisclosure

    Medicare Supplement Medical Membership

    Period endPeriodValueUnitSource
    2026-06-30instant1,176,000membersDisclosure

    PBM Plan Members

    Period endPeriodValueUnitSource
    2026-06-30instant87,000,000plan membersDisclosure

    People Served Through Health Insurance Products and Related Services

    Period endPeriodValueUnitSource
    2026-06-30instant37,000,000peopleDisclosure

    Pharmacy Claims Processed

    Period endPeriodValueUnitSource
    2026-06-30quarterly473,000,00030-day-equivalent claimsDisclosure

    Pharmacy Same-Store Sales Growth

    Period endPeriodValueUnitSource
    2026-06-30quarterly2.9percentDisclosure

    Prescriptions Filled

    Period endPeriodValueUnitSource
    2026-06-30quarterly457,000,00030-day-equivalent prescriptionsDisclosure

    Retail Locations

    Period endPeriodValueUnitSource
    2026-06-30instant9,000locationsDisclosure

    Same-Store Prescription Volume Growth

    Period endPeriodValueUnitSource
    2026-06-30quarterly7percentDisclosure

    Stand-Alone Medicare Prescription Drug Plan Membership

    Period endPeriodValueUnitSource
    2026-06-30instant3,870,000membersDisclosure

    Total Medical Membership

    Period endPeriodValueUnitSource
    2026-06-30instant26,023,000membersDisclosure

    Total Same-Store Sales Growth

    Period endPeriodValueUnitSource
    2026-06-30quarterly2.6percentDisclosure

    Walk-In and Primary Care Medical Clinics

    Period endPeriodValueUnitSource
    2026-06-30instant1,000clinicsDisclosure

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30SegmentCorporate And Other147,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentHealth Care Benefits37,507,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentHealth Services45,388,000,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentPharmacy And Consumer Health23,054,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31SegmentCorporate And Other126,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31SegmentHealth Care Benefits35,939,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31SegmentHealth Services42,609,000,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31SegmentPharmacy And Consumer Health21,752,000,000USDDisclosure
    Q4 2025Quarterly · 2025-12-31SegmentCorporate And Other122,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentHealth Care Benefits36,262,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentHealth Services44,045,000,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31SegmentPharmacy And Consumer Health25,264,000,000USDLegacy provider
    FY 2025Yearly · 2025-12-31SegmentCorporate And Other484,000,000USDDisclosure
    FY 2025Yearly · 2025-12-31SegmentHealth Care Benefits143,236,000,000USDDisclosure
    FY 2025Yearly · 2025-12-31SegmentHealth Services164,623,000,000USDDisclosure
    FY 2025Yearly · 2025-12-31SegmentPharmacy And Consumer Health93,724,000,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30SegmentCorporate And Other133,000,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30SegmentHealth Care Benefits35,944,000,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30SegmentHealth Services42,353,000,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30SegmentPharmacy And Consumer Health24,441,000,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30SegmentCorporate And Other96,000,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30SegmentHealth Care Benefits36,238,000,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30SegmentHealth Services40,115,000,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30SegmentPharmacy And Consumer Health22,466,000,000USDDisclosure
    Q4 2024Quarterly · 2024-12-31SegmentCorporate And Other83,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentHealth Care Benefits32,940,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentHealth Services42,350,000,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentPharmacy And Consumer Health22,337,000,000USDLegacy provider
    FY 2024Yearly · 2024-12-31SegmentCorporate And Other451,000,000USDDisclosure
    FY 2024Yearly · 2024-12-31SegmentHealth Care Benefits130,593,000,000USDDisclosure
    FY 2024Yearly · 2024-12-31SegmentHealth Services158,301,000,000USDDisclosure
    FY 2024Yearly · 2024-12-31SegmentPharmacy And Consumer Health83,464,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30SegmentCorporate And Other142,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30SegmentHealth Care Benefits32,978,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30SegmentHealth Services40,793,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30SegmentPharmacy And Consumer Health21,515,000,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30SegmentCorporate And Other111,000,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30SegmentHealth Care Benefits32,457,000,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30SegmentHealth Services38,692,000,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30SegmentPharmacy And Consumer Health19,974,000,000USDDisclosure
    FY 2023Yearly · 2023-12-31SegmentCorporate And Other451,000,000USDDisclosure
    FY 2023Yearly · 2023-12-31SegmentHealth Care Benefits105,565,000,000USDDisclosure
    FY 2023Yearly · 2023-12-31SegmentHealth Services174,017,000,000USDDisclosure
    FY 2023Yearly · 2023-12-31SegmentPharmacy And Consumer Health77,743,000,000USDDisclosure
    FY 2022Yearly · 2022-12-31SegmentCorporate And Other530,000,000USDDisclosure
    FY 2022Yearly · 2022-12-31SegmentHealth Care Benefits91,274,000,000USDDisclosure
    FY 2022Yearly · 2022-12-31SegmentHealth Services157,968,000,000USDDisclosure
    FY 2022Yearly · 2022-12-31SegmentPharmacy And Consumer Health72,695,000,000USDDisclosure
    FY 2019Yearly · 2019-12-31ProductOther64,133,000,000USD0000064803-22-000008
    FY 2019Yearly · 2019-12-31ProductProduct185,236,000,000USD0000064803-22-000008
    FY 2019Yearly · 2019-12-31ProductServices7,407,000,000USD0000064803-22-000008
    FY 2018Yearly · 2018-12-31ProductFront Store Revenue19,055,000,000USD0000064803-20-000007
    FY 2018Yearly · 2018-12-31ProductPharmacy Revenue164,845,000,000USD0000064803-20-000007
    FY 2018Yearly · 2018-12-31ProductPremiums8,184,000,000USD0000064803-20-000007
    FY 2018Yearly · 2018-12-31ProductProduct And Service Other1,835,000,000USD0000064803-20-000007
    FY 2018Yearly · 2018-12-31ProductServices1,825,000,000USD0000064803-20-000007
    Q3 2018Quarterly · 2018-09-30ProductFront Store Revenue4,557,000,000USD0001558370-18-008642
    Q3 2018Quarterly · 2018-09-30ProductOther Revenue944,000,000USD0001558370-18-008642
    Q3 2018Quarterly · 2018-09-30ProductPharmacy Revenue41,768,000,000USD0001558370-18-008642
    Q2 2018Quarterly · 2018-06-30ProductFront Store Revenue4,707,000,000USD0000064803-19-000039
    Q2 2018Quarterly · 2018-06-30ProductPharmacy Revenue40,947,000,000USD0000064803-19-000039
    Q2 2018Quarterly · 2018-06-30ProductPremiums751,000,000USD0000064803-19-000039
    Q2 2018Quarterly · 2018-06-30ProductProduct And Service Other303,000,000USD0000064803-19-000039
    Q2 2018Quarterly · 2018-06-30ProductServices305,000,000USD0000064803-19-000039
    Q1 2018Quarterly · 2018-03-31ProductFront Store Revenue4,726,000,000USD0000064803-19-000021
    Q1 2018Quarterly · 2018-03-31ProductOther406,000,000USD0000064803-19-000021
    Q1 2018Quarterly · 2018-03-31ProductPharmacy Revenue39,305,000,000USD0000064803-19-000021
    Q1 2018Quarterly · 2018-03-31ProductPremiums1,306,000,000USD0000064803-19-000021
    FY 2017Yearly · 2017-12-31ProductOther3,579,000,000USD0000064803-20-000007
    FY 2017Yearly · 2017-12-31ProductProduct180,063,000,000USD0000064803-20-000007
    FY 2017Yearly · 2017-12-31ProductServices1,144,000,000USD0000064803-20-000007
    FY 2016Yearly · 2016-12-31ProductPremiums3,069,000,000USD0000064803-19-000013
    FY 2016Yearly · 2016-12-31ProductProduct173,377,000,000USD0000064803-19-000013
    FY 2016Yearly · 2016-12-31ProductServices1,080,000,000USD0000064803-19-000013
    FY 2014Yearly · 2014-12-31SegmentCorporate0USD0000064803-15-000008
    FY 2014Yearly · 2014-12-31SegmentIntersegment Elimination-16,871,000,000USD0000064803-15-000008
    FY 2014Yearly · 2014-12-31SegmentPharmacy Services88,440,000,000USD0000064803-15-000008
    FY 2014Yearly · 2014-12-31SegmentRetail Pharmacy67,798,000,000USD0000064803-15-000008
    FY 2013Yearly · 2013-12-31SegmentCorporate0USD0000064803-15-000008
    FY 2013Yearly · 2013-12-31SegmentIntersegment Elimination-15,065,000,000USD0000064803-15-000008
    FY 2013Yearly · 2013-12-31SegmentPharmacy Services76,208,000,000USD0000064803-15-000008
    FY 2013Yearly · 2013-12-31SegmentRetail Pharmacy65,618,000,000USD0000064803-15-000008
    FY 2012Yearly · 2012-12-31SegmentCorporate0USD0000064803-15-000008
    FY 2012Yearly · 2012-12-31SegmentIntersegment Elimination-13,965,000,000USD0000064803-15-000008
    FY 2012Yearly · 2012-12-31SegmentPharmacy Services73,444,000,000USD0000064803-15-000008
    FY 2012Yearly · 2012-12-31SegmentRetail Pharmacy63,641,000,000USD0000064803-15-000008
    FY 2011Yearly · 2011-12-31SegmentCorporate0USD0000064803-14-000008
    FY 2011Yearly · 2011-12-31SegmentIntersegment Elimination-11,373,000,000USD0000064803-14-000008
    FY 2011Yearly · 2011-12-31SegmentPharmacy Services58,874,000,000USD0000064803-14-000008
    FY 2011Yearly · 2011-12-31SegmentRetail Pharmacy59,579,000,000USD0000064803-14-000008

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.